Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano Labs (NA) Liabilities and Shareholders Equity (2021 - 2025)

Nano Labs' Liabilities and Shareholders Equity history spans 5 years, with the latest figure at $157.8 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $157.8 million for Q4 2025, up 84.08% from a year ago — trailing twelve months through Dec 2025 was $343.9 million (up 4.73% YoY), and the annual figure for FY2025 was $155.8 million, up 81.81%.
  • Liabilities and Shareholders Equity for Q4 2025 was $157.8 million at Nano Labs, up from $85.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $157.8 million in Q4 2025 to a low of $48.7 million in Q4 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $85.7 million (2024), against an average of $97.2 million.
  • The sharpest move saw Liabilities and Shareholders Equity tumbled 63.72% in 2022, then surged 84.08% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $142.3 million in 2021, then tumbled by 63.72% to $51.6 million in 2022, then fell by 5.78% to $48.7 million in 2023, then skyrocketed by 76.25% to $85.7 million in 2024, then surged by 84.08% to $157.8 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $157.8 million, $85.7 million, and $48.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.